drugset / Trial / NCT03017235

A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy

NCT03017235 ↗

Phase 3 Completed 917 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupSingle-blindOther

Summary

The purpose of this study is to compare the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution with PREPOPIK® for colon cleansing in adult subjects undergoing colonoscopy.

Timeline

Start
2017-02-20
Primary completion
2017-09-15
Completion
2017-10-12

Outcome

Met primary endpoint

paper SPMC oral solution demonstrated non-inferiority to P/MC powder {87.7% (393/448) responders versus 81.5% (369/453) responders [difference (95% confidence interval): 6.3% (1.8, 10.9)]}. PMID 31205487 ↗

paper According to the prespecified hierarchical testing, after meeting the primary and key secondary objectives, SPMC oral solution was tested for superiority to P/MC powder for the primary endpoint (p = 0.0067). PMID 31205487 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Unknown — Oral

Indications

No indication recorded.